RT‐PCR/MALDI‐TOF mass spectrometry‐based detection of SARS‐CoV‐2 in saliva specimens-Reference-Cited by-同舟云学术

RT‐PCR/MALDI‐TOF mass spectrometry‐based detection of SARS‐CoV‐2 in saliva specimens

Published:2021-05-19 Issue:9 Volume:93 Page:5481-5486
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Hernandez Matthew M.¹^ORCID,Banu Radhika²,Shrestha Paras²,Patel Armi²,Chen Feng²,Cao Liyong²,Fabre Shelcie²,Tan Jessica³⁴,Lopez Heidi²,Chiu Numthip²,Shifrin Biana²,Zapolskaya Inessa²,Flores Vanessa²,Lee Pui Yiu²,Castañeda Sergio⁵,Ramírez Juan David⁵^ORCID,Jhang Jeffrey¹,Osorio Giuliana²,Gitman Melissa R.¹²^ORCID,Nowak Michael D.¹²^ORCID,Reich David L.⁶,Cordon‐Cardo Carlos¹,Sordillo Emilia Mia¹²^ORCID,Paniz‐Mondolfi Alberto E.¹²^ORCID

Affiliation:

1. Department of Pathology, Molecular, and Cell‐Based Medicine Icahn School of Medicine at Mount Sinai New York New York USA

2. Clinical Microbiology Laboratory, Department of Pathology, Molecular, and Cell‐Based Medicine Icahn School of Medicine at Mount Sinai New York New York USA

3. Department of Microbiology Icahn School of Medicine at Mount Sinai New York New York USA

4. The Graduate School of Biomedical Sciences Icahn School of Medicine at Mount Sinai New York New York USA

5. Departamento de Biología, Facultad de Ciencias Naturales, Grupo de Investigaciones Microbiológicas‐UR (GIMUR) Universidad del Rosario Bogotá Colombia

6. Department of Anesthesiology, Perioperative and Pain Medicine Icahn School of Medicine at Mount Sinai New York New York USA

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27069

Reference26 articles.

1. Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories

2. Laboratories and Pandemic Preparedness

3. Diagnostics in the Time of Coronavirus Disease 2019 (COVID-19)

4. In Vitro Diagnostics EUAs. U.S. Food and Drug Administration. Published Febraury 17 2021. Accessed February 21 2021.https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas#individual-molecular

5. Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A micro-disc-based multiplex method for monitoring emerging SARS-CoV-2 variants using the molecular diagnostic tool Intelli-OVI;Communications Medicine;2024-08-09

2. MassARRAY: a high-throughput solution for rapid detection of foodborne pathogens in real-world settings;Frontiers in Microbiology;2024-06-25

3. Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease;Analytical Chemistry;2024-04-30

4. A high throughput immuno-affinity mass spectrometry method for detection and quantitation of SARS-CoV-2 nucleoprotein in human saliva and its comparison with RT-PCR, RT-LAMP, and lateral flow rapid antigen test;Clinical Chemistry and Laboratory Medicine (CCLM);2024-01-23

5. Perspective Chapter: Predictive Genomics;Electron Microscopes, Spectroscopy and Their Applications;2024-01-03